EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma.

Shan Xu,Bohan Ma,Xiaoyu Feng,Chen Yao,Yanlin Jian,Yule Chen,Xinyang Wang,Hongjun Xie,Lei Li

Translational andrology and urology（2023）

引用 0|浏览56

暂无评分

摘要

The EZH2-regulated immune-risk score prognostic model was an independent prognostic factor, with good accuracy and predictability, and could provide experimental data to the clinical area.

查看译文

关键词

Enhancer of zeste homolog 2 (EZH2),immunomodulators,overall survival (OS),renal cell carcinoma (RCC)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要